<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lipid-lowering medications in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lipid-lowering medications in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Lipid-lowering medications in children</div><div class="cntnt"><table cellspacing="0"><colgroup width="10%"></colgroup><colgroup span="5" width="18%"></colgroup> <tbody> <tr> <td class="subtitle1">Class</td> <td class="subtitle1">Drug</td> <td class="subtitle1">Initial daily dose</td> <td class="subtitle1">Upper daily dose studied in clinical trials (children aged ≥10 years)<sup>[1]</sup></td> <td class="subtitle1">Maximum daily dose (adult)</td> <td class="subtitle1">Available strengths (United States)</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Statins</td> </tr> <tr> <td class="divider_bottom" rowspan="6"> </td> <td>Atorvastatin</td> <td>5 to 10 mg</td> <td>20 mg</td> <td>80 mg</td> <td>10, 20, 40, 80 mg</td> </tr> <tr> <td>Fluvastatin</td> <td>20 mg</td> <td>80 mg</td> <td>80 mg</td> <td>20, 40 mg, 80 mg (extended release)</td> </tr> <tr> <td>Lovastatin</td> <td>10 mg</td> <td>40 mg</td> <td>80 mg</td> <td> <p>10, 20, 40 mg</p> 20, 40, 60 mg (extended release)</td> </tr> <tr> <td>Pravastatin</td> <td>10 mg</td> <td> <p>40 mg (age 14 to 18 years)</p> 20 mg (age 8 to 13 years)</td> <td>80 mg</td> <td>10, 20, 40, 80 mg</td> </tr> <tr> <td>Rosuvastatin</td> <td>5 mg</td> <td>20 mg</td> <td>40 mg</td> <td>5, 10, 20, 40 mg</td> </tr> <tr class="divider_bottom"> <td>Simvastatin<sup>​</sup></td> <td> <p>10 mg (age ≥10 years)</p> 5 mg (age 10 years)</td> <td>40 mg</td> <td>40 mg</td> <td>5, 10, 20, 40, 80<sup>¶</sup> mg</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Cholesterol absorption inhibitors</td> </tr> <tr class="divider_bottom"> <td> </td> <td>Ezetimibe</td> <td>10 mg</td> <td>10 mg</td> <td>10 mg</td> <td>10 mg</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Fibric acid derivates</td> </tr> <tr> <td class="divider_bottom" rowspan="2"> </td> <td>Gemfibrozil</td> <td>1200 mg<sup>*</sup></td> <td>Data lacking</td> <td>1200 mg</td> <td>600 mg</td> </tr> <tr class="divider_bottom"> <td>Fenofibrate</td> <td>40 mg</td> <td>Data lacking</td> <td>130 to 200 mg (maximum dose depends on preparation; see Lexicomp drug reference)</td> <td>40, 43, 48, 50, 54, 67, 100, 120, 134, 145, 160, 200 mg (available strengths vary by preparation; see Lexicomp drug reference)</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Bile acid sequestrants</td> </tr> <tr> <td class="divider_bottom" rowspan="3"> </td> <td>Cholestyramine</td> <td>2 to 4 g or 240 mg/kg per day</td> <td> <p>8 g</p> 4 g (age &lt;10 years)</td> <td>16 g</td> <td>4 g per packet or scoop</td> </tr> <tr> <td>Colestipol</td> <td>2.5 to 5 g</td> <td>12 g</td> <td>20 g</td> <td> <p>5 g per packet or scoop</p> 1 g tablet</td> </tr> <tr class="divider_bottom"> <td>Colesevelam</td> <td>1.25 g</td> <td>3.75 g</td> <td>3.75 g</td> <td> <p>3.75 g per packet</p> 625 mg tablet</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Omega-3 fish oils</td> </tr> <tr> <td> </td> <td>Omega-3 acid ethyl esters</td> <td>1 g</td> <td>Data lacking</td> <td>4 g</td> <td>1 g (many strengths available)</td> </tr> </tbody></table></div><div class="graphic_lgnd">Always review drug interactions upon initiation and alteration of treatment. Specific interactions may be determined using the drug interactions tool (Lexi-Interact Online) included with UpToDate. This tool can be accessed from the UpToDate online search page or through the individual drug information topics in the section on Drug interactions.<br/>Children and adolescents are generally <strong>not </strong>managed with more than one class of lipid-lowering agents due to increased risk of side effects. Combinations of statins and fibrates should be administered under the supervision of a pediatric lipid specialist.</div><div class="graphic_footnotes">LDL-C: low-density lipoprotein cholesterol.<br/>* An initial 600 mg daily dose of gemfibrozil may be considered. Data in children are lacking.<br/><sup>¶</sup>​ The US Food and Drug Administration has placed a black box label on simvastatin at a dose of 80 mg per day because it is associated with muscle toxicity in adults. If a daily dose of 40 mg of simvastatin is insufficient to achieve LDL-C control, a change to a more potent statin (eg, atorvastatin or rosuvastatin) is suggested. Doses of simvastatin that exceed 40 mg per day should be given under the supervision of a pediatric lipid specialist, and are generally not required, as more potent statins are available.</div><div class="graphic_reference">Reference: 

<ol>
<li>Data from: Daniels DR, Benuck I, Christakis DA, et al. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report-2011. National Heart Lung and Blood Institute. Available at: <a href="https://www.nhlbi.nih.gov/node/80139">https://www.nhlbi.nih.gov/node/80139</a> (Accessed April 4, 2012).</li></ol></div><div id="graphicVersion">Graphic 69650 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
